Home » Stocks » Elanco Animal Health

Elanco Animal Health Incorporated (ELAN)

Stock Price: $21.21 USD 0.02 (0.09%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 8.46B
Revenue (ttm) 3.00B
Net Income (ttm) -12.70M
Shares Out 398.89M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE 28.49
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 2, 2020
Last Price $21.21
Previous Close $21.19
Change ($) 0.02
Change (%) 0.09%
Day's Open 21.42
Day's Range 21.04 - 21.61
Day's Volume 2,467,336
52-Week Range 15.17 - 35.23

More Stats

Market Cap 8.46B
Enterprise Value 9.31B
Earnings Date (est) Aug 18, 2020
Ex-Dividend Date n/a
Shares Outstanding 398.89M
Float 398.23M
EPS (basic) -0.02
EPS (diluted) -0.04
FCF / Share 0.02
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 0.11%
Payout Ratio n/a
Shares Short 12.56M
Short Ratio 2.43
Short % of Float 3.52%
Beta n/a
PE Ratio n/a
Forward PE 28.49
P/FCF Ratio 909.74
PS Ratio 2.82
PB Ratio 1.31
Revenue 3.00B
Operating Income 40.20M
Net Income -12.70M
Free Cash Flow 9.30M
Net Cash -844.50M
Net Cash / Share -2.12
Gross Margin 53.40%
Operating Margin 1.34%
Profit Margin -0.40%
FCF Margin 0.31%
ROA 2.04%
ROE -0.21%
ROIC 0.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (12)

Buy 7
Overweight 0
Hold 5
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$27.00*
(27.30% upside)
Low
23.0
Current: 21.21
High
34.0
Target: 27.00
*Average 12-month price target from 7 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015
Revenue3,0713,0672,8892,9142,909
Revenue Growth0.14%6.15%-0.84%0.15%-
Gross Profit1,6011,4931,3951,5051,375
Operating Income157144-233-22.40-258
Net Income67.9086.50-311-47.90-211
Shares Outstanding369314293293-
Earnings Per Share0.180.28-1.06-0.16-
EPS Growth-35.71%----
Operating Cash Flow2244871741566.60
Capital Expenditures-197-127-79.50-103-79.80
Free Cash Flow27.0036094.3053.00-73.20
Cash & Equivalents3456783232590.00
Total Debt2,3552,472---
Net Cash / Debt-2,010-1,7953232590.00
Assets8,9868,9578,9408,100-
Liabilities3,4393,7591,1601,072-
Book Value5,5475,1987,7807,028-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Elanco Animal Health Incorporated
Country United States
Employees 6,000
CEO Jeffrey N. Simmons

Stock Information

Ticker Symbol ELAN
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NYSE: ELAN
IPO Date September 20, 2018

Description

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for companion and food animals. It offers companion animal disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks; companion animal therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as functional nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production. The company sells its products to third-party distributors; veterinarians; and food animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations in approximately 90 countries in North America, Europe, the Middle East, Africa, Latin America, and the Asia-Pacific. The company has a research and development collaboration with AgBiome, Inc. to develop nutritional health products for swine; and strategic alliance with the Purdue University and Purdue Research Foundation. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.